Haemonetics elects Diane M. Bryant to board, shareholders approve amended LTIP with 2.97M new shares

HAEMONETICS CORP

Diane M. Bryant elected to board effective 8/4/2023; former CEO of NovaSignal, ex-COO of Google Cloud, 32-year Intel veteran.
Bryant appointed to Compensation and Technology Committees; receives standard non-employee director comp with ~$200k annual equity award.
Shareholders approved amended 2019 LTIP authorizing 2,966,231 new shares for issuance and extending plan to August 3, 2033.
All eight director nominees elected; advisory say-on-pay approved with 44.96M for; Ernst & Young ratified as auditor.

item 5.02 item 5.07 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Diane M. Bryant

Director

HAE · HAEMONETICS CORP

Effective: 2023-08-04
Filed: August 7, 2023, 7:59 PM ET

On August 4, 2023, the Board of Directors of Haemonetics Corporation (the “Company”) elected Diane M. Bryant as a director of the Company, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Diane M. Bryant was elected as Director at HAEMONETICS CORP.

Action: elected
Role: Director

Exact text from the filing

On August 4, 2023, the Board of Directors of Haemonetics Corporation (the “Company”) elected Diane M. Bryant as a director of the Company, effective immediately.

View on SEC.gov

HAEMONETICS CORP filing history →

Source: SEC EDGAR

accession 0000313143-23-000037

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.